1245.36.10011 Boehringer Ingelheim Investigational Site is a clinical research site located in Spokane, Washington, United States.
Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.
1245.36.10011 Boehringer Ingelheim Investigational Site has participated in 1 clinical trials.
Therapeutic areas: Diabetes Mellitus, Type 2, Renal Insufficiency.
Sponsors: Boehringer Ingelheim.
Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
1245.36.10011 Boehringer Ingelheim Investigational Site has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
1245.36.10011 Boehringer Ingelheim Investigational Site has 1 clinical trials on record. Their work covers Diabetes Mellitus, Type 2, Renal Insufficiency.
1245.36.10011 Boehringer Ingelheim Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.